111 related articles for article (PubMed ID: 23334251)
21. Development of a Multi-Institutional Prediction Model for Three-Year Survival Status in Patients with Uterine Leiomyosarcoma (AGOG11-022/QCGC1302 Study).
Tse KY; Wong RW; Chao A; Ueng SH; Yang LY; Cummings M; Smith D; Lai CR; Lau HY; Yen MS; Cheung AN; Leung CK; Chan KS; Chan AN; Li WH; Choi CK; Pong WM; Hui HF; Yuk JY; Yao H; Yuen NW; Obermair A; Lai CH; Ip PP; Ngan HY
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069227
[TBL] [Abstract][Full Text] [Related]
22. Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?
De Wispelaere W; Annibali D; Tuyaerts S; Lambrechts D; Amant F
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922556
[TBL] [Abstract][Full Text] [Related]
23. Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas.
Schaefer IM; Lundberg MZ; Demicco EG; Przybyl J; Matusiak M; Chibon F; Ingram DR; Hornick JL; Wang WL; Bauer S; Baker LH; Lazar AJ; van de Rijn M; Mariño-Enríquez A; Fletcher JA
Cancer; 2021 Aug; 127(15):2666-2673. PubMed ID: 33788262
[TBL] [Abstract][Full Text] [Related]
24. Neck subcutaneous nodule as first metastasis from broad ligament leiomyosarcoma: a case report and review of literature.
Cazzato F; D'Ercole A; De Luca G; Aiello FB; Croce A
BMC Surg; 2020 Nov; 20(1):297. PubMed ID: 33238975
[TBL] [Abstract][Full Text] [Related]
25. Skull Metastasis From Uterine Leiomyosarcoma, a Rare Presentation for a Rare Tumor: A Case Report and Review of the Literature.
Rizzo A; Nigro MC; Ramponi V; Gallo C; Perrone AM; De Iaco P; Frezza G; Balestrini D; Di Benedetto M; Morbiducci J; Pantaleo MA; Nannini M
Front Oncol; 2020; 10():869. PubMed ID: 32612948
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of patients with pelvic leiomyosarcoma treated by surgery and relevant auxiliary diagnosis.
Sun Q; Yang X; Zeng Z; Wei X; Li KZ; Xu XY
World J Clin Cases; 2020 May; 8(10):1887-1896. PubMed ID: 32518778
[TBL] [Abstract][Full Text] [Related]
27. Important prognostic factors in leiomyosarcoma survival: a National Cancer Database (NCDB) analysis.
Gootee J; Sioda N; Aurit S; Curtin C; Silberstein P
Clin Transl Oncol; 2020 Jun; 22(6):860-869. PubMed ID: 31392646
[TBL] [Abstract][Full Text] [Related]
28. Ewing's sarcoma of the cervix: A case report of an unusual diagnosis in pregnancy treated with surgery, adjuvant VIDE and radiotherapy.
Kyriazoglou A; Tsironis G; Liontos M; Papakosta A; Mahaira L; Thomakos N; Morphopoulos G; Papaspyrou I; Bamias A
Oncol Lett; 2019 Jun; 17(6):5529-5535. PubMed ID: 31186774
[TBL] [Abstract][Full Text] [Related]
29. The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium.
Rubisz P; Ciebiera M; Hirnle L; Zgliczyńska M; Łoziński T; Dzięgiel P; Kobierzycki C
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845657
[TBL] [Abstract][Full Text] [Related]
30. Management of uterine sarcomas and prognostic indicators: real world data from a single-institution.
Kyriazoglou A; Liontos M; Ziogas DC; Zagouri F; Koutsoukos K; Tsironis G; Tsiara A; Kaparelou M; Zakopoulou R; Thomakos N; Haidopoulos D; Papaspyrou I; Rodolakis A; Bamias A; Dimopoulos MA
BMC Cancer; 2018 Dec; 18(1):1247. PubMed ID: 30541504
[TBL] [Abstract][Full Text] [Related]
31. Identification of key genes and pathways in uterine leiomyosarcoma through bioinformatics analysis.
Zang Y; Gu L; Zhang Y; Wang Y; Xue F
Oncol Lett; 2018 Jun; 15(6):9361-9368. PubMed ID: 29844831
[TBL] [Abstract][Full Text] [Related]
32. Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma.
Baek MH; Park JY; Park Y; Kim KR; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Gynecol Oncol; 2018 May; 29(3):e30. PubMed ID: 29533018
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors.
Bilancia R; Nardini M; Waller D
J Thorac Dis; 2017 Oct; 9(Suppl 12):S1316-S1321. PubMed ID: 29119020
[TBL] [Abstract][Full Text] [Related]
34. Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma.
Dantas-Barbosa C; Lesluyes T; Loarer FL; Chibon F; Treilleux I; Coindre JM; Meeus P; Brahmi M; Bally O; Ray-Coquard I; Sunyach MP; Cesne AL; Mir O; Bonvalot S; Toulmonde M; Italiano A; Saintigny P; Jean-Denis M; Ducimetiere F; Ranchere D; El Sayadi H; Alberti L; Blay JY
Br J Cancer; 2017 Dec; 117(12):1787-1797. PubMed ID: 29024938
[TBL] [Abstract][Full Text] [Related]
35. Extensively Metastasizing Leiomyosarcoma: A Diagnostic Challenge.
Ahuja A; Agarwal P; Sardana R; Bhaskar S
J Midlife Health; 2017; 8(3):148-150. PubMed ID: 28983164
[TBL] [Abstract][Full Text] [Related]
36. High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth.
de Graaff MA; Malu S; Guardiola I; Kruisselbrink AB; de Jong Y; Corver WE; Gelderblom H; Hwu P; Nielsen TO; Lazar AJ; Somaiah N; Bovée JVMG
Transl Oncol; 2017 Aug; 10(4):546-554. PubMed ID: 28654818
[TBL] [Abstract][Full Text] [Related]
37. Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience.
Wang Z; Shi N; Naing A; Janku F; Subbiah V; Araujo DM; Patel SR; Ludwig JA; Ramondetta LM; Levenback CF; Ramirez PT; Piha-Paul SA; Hong D; Karp DD; Tsimberidou AM; Meric-Bernstam F; Fu S
Cancer Med; 2016 Dec; 5(12):3437-3444. PubMed ID: 27882721
[TBL] [Abstract][Full Text] [Related]
38. Molecular Targets and Emerging Therapeutic Options for Uterine Leiomyosarcoma.
Miller H; Ike C; Parma J; Masand RP; Mach CM; Anderson ML
Sarcoma; 2016; 2016():7018106. PubMed ID: 27721667
[TBL] [Abstract][Full Text] [Related]
39. Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.
Liegl-Atzwanger B; Heitzer E; Flicker K; Müller S; Ulz P; Saglam O; Tavassoli F; Devouassoux-Shisheboran M; Geigl J; Moinfar F
Mod Pathol; 2016 Oct; 29(10):1262-77. PubMed ID: 27363490
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Bcl-2 family members sensitises soft tissue leiomyosarcomas to chemotherapy.
de Graaff MA; de Rooij MA; van den Akker BE; Gelderblom H; Chibon F; Coindre JM; Marino-Enriquez A; Fletcher JA; Cleton-Jansen AM; Bovée JV
Br J Cancer; 2016 May; 114(11):1219-26. PubMed ID: 27140314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
